Perbedaan BFI Finance Indonesia Tbk dan Merck Tbk.: BFI Finance Indonesia Tbk diperdagangkan di Rp785 (kapitalisasi pasar 12,03 T, volume 24 jam 12,2 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.740 (kapitalisasi pasar 1,68 T, volume 24 jam 22,8 rb). Perbedaan utamanya: BFI Finance Indonesia Tbk jauh lebih besar — sekitar 7,2× kapitalisasi pasar Merck Tbk., dan BFI Finance Indonesia Tbk lebih aktif diperdagangkan (12,2 jt vs 22,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BFIN | MERK | |
|---|---|---|
Kapitalisasi Pasar | 12,03 T | 1,68 T |
Volume | 12,2 jt | 22,8 rb |
Lot | 122 rb | 228 |
Perputaran | 9,55 M | 82,9 jt |
Harga Rata-rata | 782,93 | 3.636,14 |
Nilai Transaksi | 9,55 M | 82,9 jt |
Harga Ekuilibrium Indikatif | 785 | 3.520 |
Volume Ekuilibrium Indikatif | 5,52 rb | 60 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Selengkapnya di halaman BFIN →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →